Beranda › Kanker Pankreas › North Carolina › Durham
Uji klinis Kanker Pankreas di Durham, NC
24 studi untuk Kanker Pankreas mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Menerima pesertaSukarelawan sehat diterima
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
A Study of PHN-012 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Menerima pesertaFase 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi jauhnya
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Menerima pesertaFase 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Menerima pesertaFase 3
- Investigative Site US035, Chapel Hill · 10 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Menerima pesertaFase 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
Menerima peserta
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Menerima pesertaStudi observasional
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi jauhnya
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Menerima pesertaFase 2
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Menerima pesertaFase 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 mi jauhnya
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Menerima pesertaFase 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Menerima pesertaFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Menerima pesertaFase 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Menerima pesertaFase 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Menerima pesertaFase 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Menerima pesertaFase 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Menerima pesertaFase 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Menerima pesertaFase 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauhnya
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Menerima pesertaFase 2
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Uji klinis Kanker Pankreas di kota lain
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Arlington, VA33 studi
- Baltimore, MD31 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Tampa, FL26 studi
- San Diego, CA24 studi
Studi lain di Durham
- Kanker Payudara64 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Leukemia Mieloid Akut33 studi
- Kanker Metastatik33 studi
- Kanker Prostat32 studi
- Kanker Paru32 studi
- Kanker Kolorektal28 studi
- Kanker Ovarium27 studi
- Leukemia Limfositik Kronis27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.